Serum Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) as a Potential Biomarker for Diagnosis of Hepatocellular Carcinoma.

Ziran WangLingjun KongRui ZhangXiaobo YangZhe CaoTeng-Da XuHan ZhangYaling Dou

Published in: Journal of hepatocellular carcinoma (2024)

Our study demonstrated that serum AKR1B10 is a promising biomarker for HCC, and when used in combination with AFP can significantly improve the detection rate of HCC.

Keyphrases

label free
sensitive detection